Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?
Semin Oncol
; 47(6): 353-354, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-33153752
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fees, Pharmaceutical
/
Antineoplastic Agents
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Semin Oncol
Year:
2020
Document type:
Article
Affiliation country:
Canada